Our research mainly focuses on genetics of ALS, stem cell therapeutics, and ALS disease mechanisms. We also conduct clinical studies to identify new biomarkers and are involved in clinical trials.
LocationInternational Medical School, University of Milan, Milan, Metropolitan City of Milan, Italy
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.